Small-cap multibagger inventory: Sampre Nutritions will probably be within the focus of inventory market buyers on Monday, 15 September 2025, after the corporate shares have hit their higher circuit for 65 days in a row on the Indian inventory market.
BSE knowledge exhibits that the corporate shares have an higher worth band of ₹97.57, whereas the cheaper price band of the Sampre Nutritions shares are at ₹20.90, with a worth tolerance band of two%.
Conversion of warrants
Sampre Diet’s board of administrators introduced on Friday, 12 September 2025, that they’ve authorised the allotment of 5,50,000 or 5.50 lakh fairness shares with a face worth of ₹10 apiece upon conversion of share warrants issued at a preferential foundation.
Promoter Brahma Gurbani was allotted 5 lakh share warrants for conversion, whereas public shareholder Vishal Ratan Gurbani was allotted 50,000 share warrants for conversion.
The BSE submitting additionally revealed that the allotment of fairness shares was made after the corporate acquired the remaining train worth of ₹45.375 per warrant, amounting to ₹2,49,56,250 or over ₹2.49 crore.
“Consequent to the aforesaid allotment, the paid-up fairness capital of the Firm has elevated from ₹21,00,68,550 solely consisting of two,10,06,855 fairness shares of ₹10 per share, to ₹21,55,68,550, consisting of two,15,56,855 fairness shares of ₹10 per share,” the corporate knowledgeable BSE by way of the submitting knowledge.
Sampre Nutritions Share Value Pattern
Sampre Nutritions share worth closed 1.99% larger at ₹95.66 after hitting the higher circuit on Friday’s inventory market session, in comparison with ₹93.79 on the earlier market session.
The shares of the confectionery producer have given inventory market buyers greater than 607% returns on their funding within the final 5 years and over 20% features within the final one-year interval. The inventory has gained practically 250% within the final six month on the inventory market.
On a year-to-date (YTD) foundation, the Sampre Nutritions shares have jumped over 52% in 2025 and are up 48.40% within the final one month interval. The corporate’s shares are buying and selling 8.21% larger within the final 5 market classes on the Indian inventory market.
Sampre Nutritions’ inventory hit its 52-week excessive stage at ₹101.17 on 11 November 2024, whereas the 52-week low stage was at ₹20.90 on 28 March 2025, in keeping with the info collected from the BSE web site.
The corporate’s market capitalisation (M-Cap) stood at ₹200.95 crore as of the inventory market shut on Friday, 12 September 2025.
Learn all tales by Anubhav Mukherjee
Disclaimer: This story is for instructional functions solely. The views and proposals above are these of particular person analysts or broking corporations, not Mint. We advise buyers to test with licensed consultants earlier than making any funding choices.
